| Title: | Genetic impact of blood C-reactive protein levels on chronic spinal & widespread pain |
| Journal: | European Spine Journal |
| Published: | 17 Apr 2023 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/37069442/ |
| DOI: | https://doi.org/10.1007/s00586-023-07711-7 |
| URL: | https://link.springer.com/content/pdf/10.1007/s00586-023-07711-7.pdf |
| Citations: | 3 (3 in last 2 years) as of 8 Aug 2024 |
Publication 11350
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
PurposeCausal mechanisms underlying systemic inflammation in spinal & widespread pain remain an intractable experimental challenge. Here we examined whether: (i) associations between blood C-reactive protein (CRP) and chronic back, neck/shoulder & widespread pain can be explained by shared underlying genetic variants; and (ii) higher CRP levels causally contribute to these conditions.MethodsUsing genome-wide association studies (GWAS) of chronic back, neck/shoulder & widespread pain (N = 6063-79,089 cases; N = 239,125 controls) and GWAS summary statistics for blood CRP (Pan-UK Biobank N = 400,094 & PAGE consortium N = 28,520), we employed cross-trait bivariate linkage disequilibrium score regression to determine genetic correlations (rG) between these chronic pain phenotypes and CRP levels (FDR < 5%). Latent causal variable (LCV) and generalised summary data-based Mendelian randomisation (GSMR) analyses examined putative causal associations between chronic pain & CRP (FDR < 5%).ResultsHigher CRP levels were genetically correlated with chronic back, neck/shoulder & widespread pain (rG range 0.26-0.36; P ≤ 8.07E-9; 3/6 trait pairs). Although genetic causal proportions (GCP) did not explain this finding (GCP range − 0.32-0.08; P ≥ 0.02), GSMR demonstrated putative causal effects of higher CRP levels contributing to each pain type (beta range 0.027-0.166; P ≤ 9.82E-03; 3 trait pairs) as well as neck/shoulder pain effects on CRP levels (beta [S.E.] 0.030 [0.021]; P = 6.97E-04).ConclusionThis genetic evidence for higher CRP levels in chronic spinal (back, neck/shoulder) & widespread pain warrants further large-scale multimodal & prospective longitudinal studies to accelerate the identification of novel translational targets and more effective therapeutic strategies.</p>
10 Authors
- Scott F. Farrell
- Michele Sterling
- David M. Klyne
- Sanam Mustafa
- Adrián I. Campos
- Pik-Fang Kho
- Mischa Lundberg
- Miguel E. Rentería
- Trung Thanh Ngo
- Gabriel Cuéllar-Partida
1 Application
| Application ID | Title |
|---|---|
| 25331 | Gene mapping and genetic correlation across complex traits |
Enabling scientific discoveries that improve human health